How do you decide if a fractional CRO is right for a Series A company when churn is rising on enterprise accounts?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

The Enterprise Buyer Committee at Series A

At Series A, your enterprise accounts are typically companies with 200-1,000 employees, and the buying committee is a fragile, often adversarial group. You are not selling to a single champion - you are navigating a committee that includes a VP-level operational buyer (the person who will use your tool daily), a procurement manager who has been burned by startups before, and a senior executive (often a CTO or CFO) who is skeptical of your company's longevity. The VP buyer evaluates your product on workflow integration and time-to-value, but the procurement manager scrutinizes your SOC 2 certification, your uptime SLAs, and your ability to survive a funding winter. The executive cares about strategic alignment - does your solution reduce their operating costs by a defensible margin, or is it a "nice to have" that will be cut in the next budget review? Deals stall at the "security review" stage because your Series A company lacks the compliance documentation that enterprises demand, or at the "legal review" stage because your standard terms don't include the indemnification clauses or data residency commitments that their counsel requires. Typical deal sizes range from $50,000 to $150,000 in annual recurring revenue, but the budget approval process is torturous: the VP buyer must build a business case justifying the expense to their director, who then presents to a steering committee that includes the CFO. The budget is not a separate line item - it must be carved out of an existing cost center, meaning the buyer is essentially cannibalizing their own headcount or software budget to fund your deal. This dynamic creates a cycle of false urgency: the champion is motivated, but the committee moves at a glacial pace, and your sales reps lack the executive access to unstick the process.

Sales Cycle Implications of Rising Enterprise Churn

Rising churn on enterprise accounts forces a specific sales motion that is uniquely punishing at Series A. Your sales cycle, which should be 60-90 days, stretches to 120-180 days because every new deal is now shadowed by the churn data from existing accounts. Prospects in the pipeline hear from their peers about implementation headaches or support gaps, and your reps spend 40% of their time in "trust restoration" conversations rather than value selling. The forecast becomes a fiction: your CRM shows a pipeline of $2 million in weighted opportunities, but 60% of those deals are stuck in "evaluation" with no next steps because the champion is waiting for internal references that your churned accounts cannot provide. The leaks are not at the top of the funnel - you still generate leads from your Series A brand awareness and inbound content - but at the "technical validation" and "commercial negotiation" stages. Your implementation team is overwhelmed because churned accounts often left due to poor onboarding, so new enterprise prospects demand extended proof-of-concept periods (6-8 weeks instead of 2-3) to verify that your tool actually works in their environment. Ramp expectations collapse: a new enterprise AE hired at Series A typically needs 6 months to close their first deal, but with churn rising, that ramp extends to 9-12 months because they must personally invest time in reference-building. Your pipeline shape shifts from a healthy pyramid (many small deals at top, few large at bottom) to an inverted funnel: you have a handful of large enterprise opportunities that are all high-risk, and your mid-market and SMB deals are drying up because you have pulled your marketing resources to chase enterprise logos. The revenue team is caught in a doom loop: to hit quarterly targets, they discount enterprise deals to close faster, which attracts price-sensitive buyers who churn even faster, compounding the problem.

What a Fractional CRO Looks Like Here

A fractional CRO for a Series A company with rising enterprise churn is not a generalist - they are a specific archetype: a former VP of Sales or CRO who has personally fixed a broken enterprise sales motion at a startup of similar scale, ideally in the same vertical or adjacent industry. They are not a "strategic advisor" who shows up for a weekly call and sends a slide deck - they are an operator who sits in your office (or joins your daily standups remotely) for 3-4 days per week for the first 90 days. Their mandate is narrow and brutal: stabilize the existing enterprise book of business, diagnose the churn root cause, and build a repeatable playbook for closing new enterprise deals at a 90%+ retention rate. They own the full revenue stack: sales, customer success, and revenue operations, but they do not own product or marketing strategy - they advise on messaging and positioning but defer to the founder on roadmap decisions. In the first 30 days, they conduct 20 "churn autopsies" with lost accounts, mapping each exit to a specific failure point: was it a sales overpromise, a product gap, a poor implementation, or a pricing mismatch? They then build a "red-yellow-green" health score for every remaining enterprise account, flagging the 10-15 accounts at highest risk of churning in the next quarter. Days 31-60 are about surgical intervention: they personally join QBRs for the red accounts, negotiate retention discounts or contract modifications, and implement a 48-hour response SLA for all enterprise support tickets. They also rewrite the enterprise sales playbook: qualifying criteria now include a mandatory reference call with a current customer of similar size, a technical validation checklist that must be signed by the prospect's IT team, and a "no discount without board approval" rule for deals over $75,000. Days 61-90 are about building the operating cadence: a weekly revenue review that tracks not just pipeline and forecast but also churn velocity, implementation completion rates, and Net Promoter Score from enterprise accounts. The fractional CRO's operating cadence is intense: daily 15-minute standups with the sales team, weekly 60-minute pipeline reviews with the founder, and bi-weekly board updates on churn metrics. They convert to full-time only if, after 90 days, the churn rate has dropped by at least 30% (from the baseline at engagement start) and the enterprise sales cycle has shortened by at least 20%. The signal to convert is not a single quarter of improvement - it is when the founder realizes that the fractional CRO's presence is the only thing preventing the company from entering a death spiral, and the cost of hiring them full-time ($250,000-$350,000 base plus equity) is cheaper than the revenue lost to continued churn. If the churn is not improving by day 60, the fractional CRO should recommend a full-time hire with a different skill set - someone who can lead a product pivot or a market repositioning, not just a sales fix.

The Board and Investor Dynamics

Your Series A board is watching this situation with a microscope because rising enterprise churn at this stage is a leading indicator of a broken business model. The board's expectation is not that you eliminate churn entirely - they know that some churn is normal at Series A - but that you demonstrate a clear, data-driven plan to reduce it by 50% within two quarters. The fractional CRO must be able to speak the board's language: they should present churn as a cohort analysis (e.g., "accounts acquired in Q1 2023 churned at 15% per quarter, while accounts acquired in Q3 2023 churned at 8% per quarter because we changed the implementation process"). The board will pressure the founder to make a fast decision on the fractional CRO because they have seen too many startups burn cash on a full-time CRO who takes 6 months to diagnose the same problem. Investors will also scrutinize the fractional CRO's compensation: a typical engagement costs $15,000-$25,000 per month for a 3-4 day per week commitment, plus a small equity grant (0.5-1.0% vested over 12 months). The board wants to see that this cost is offset by a measurable reduction in churn-related revenue loss - if your enterprise ARR is $2 million and churn is running at 20% annually, a fractional CRO who cuts that to 10% saves you $200,000 in retained revenue, making the engagement a clear ROI. However, the board will also demand a "break glass" plan: if the fractional CRO fails to move the needle by month three, what is the backup? The answer is usually a full-time VP of Customer Success hire who can own retention while the founder takes over sales personally, or a pivot to mid-market where the sales cycle is shorter and churn is easier to manage.

The Founder's Role in This Decision

The founder must be brutally honest about whether they have the time and ego to work with a fractional CRO. At Series A, the founder is often the de facto head of sales, and rising churn means they are spending 60% of their week on customer complaints and deal rescues. A fractional CRO will demand that the founder cede control over sales process, compensation plans, and customer escalation decisions - if the founder cannot do that, the engagement will fail. The founder must also be willing to accept that the fractional CRO's diagnosis may be painful: the churn might be caused by the founder's own overpromises during early enterprise sales (e.g., custom features that were never built, or SLAs that the team cannot support). The founder's job in the first 90 days is to be the "executive sponsor" for the fractional CRO's changes: they must personally attend the weekly revenue reviews, approve the new discount policies, and communicate to the board that the fractional CRO has full authority to restructure the sales team if needed. If the founder is already stretched thin by fundraising or product development, the fractional CRO will become a bottleneck - they will spend their time waiting for founder approvals rather than executing. The founder should only hire a fractional CRO if they can commit to 5 hours per week of direct collaboration, including a weekly 90-minute strategy session where they review churn data, pipeline health, and team performance. If the founder cannot make that time, they should instead hire a full-time VP of Sales who can operate independently, even if that hire takes 3 months to find.

The Competitive Landscape Trap

A unique danger at Series A with rising enterprise churn is that the fractional CRO might inadvertently steer the company into a competitive pricing war. When churn is rising, the natural instinct is to discount enterprise deals to keep logos, but a fractional CRO who has seen this movie before knows that discounting attracts the wrong buyers - companies that will churn as soon as a cheaper alternative appears. Instead, the fractional CRO should focus on "value-based retention": they should analyze the 10-15 enterprise accounts that have not churned and identify the common thread in their usage patterns, then build a "customer health score" that predicts churn with 80% accuracy. For example, if the retained accounts all use a specific feature (like API integrations or custom reporting) at least 3 times per week, the fractional CRO should mandate that every new enterprise deal includes a 30-day onboarding plan that trains the customer on that feature. This approach is counterintuitive at Series A because it feels slower than discounting, but it builds a retention moat that discounting cannot. The fractional CRO must also resist the temptation to "fire" the churning accounts too quickly - a Series A company cannot afford to lose any enterprise revenue, but they can afford to invest in a 60-day "save campaign" that includes executive engagement, product training, and a contract renegotiation. The competitive trap is that your competitors are likely also Series A or Series B, and they are watching your churn data as a signal to poach your accounts. If your fractional CRO can stabilize churn within 90 days, you buy yourself time to build a defensible product roadmap; if they cannot, your competitors will pick off your top 10 accounts and your Series A runway will evaporate.

FAQ

A question? How do I know if my rising churn is a sales problem or a product problem before hiring a fractional CRO? Conduct a "churn autopsy" on your last 10 lost enterprise accounts: if 7 out of 10 cite "implementation complexity" or "unclear ROI" as the reason, it is a sales motion problem; if 7 out of 10 cite "missing features" or "competitor product superiority," it is a product problem. A fractional CRO can only fix the former - if the product is the issue, invest in a VP of Product instead.

A question? What is the maximum monthly cost I should pay for a fractional CRO at Series A? Your monthly cost should not exceed 10% of your enterprise ARR lost to churn per month. For example, if your enterprise churn is $50,000 per month in lost revenue, the fractional CRO should cost no more than $5,000 per month for a part-time engagement, or $15,000-$20,000 per month for a 4-day per week commitment. Any higher, and you are better off hiring a full-time VP of Sales with a lower base salary and higher equity.

A question? Should I ask the fractional CRO to also manage customer success? Yes, but only if the churn is caused by poor handoff between sales and onboarding. At Series A, the line between sales and customer success is blurry - the fractional CRO should own both functions for the first 90 days to ensure that the "implementation promise" made in the sales process is actually delivered. If the churn is caused by product gaps or pricing, the fractional CRO should hand customer success to a dedicated hire after day 60.

A question? How do I measure the fractional CRO's performance in the first 30 days? Track three metrics: churn velocity (are you losing accounts faster or slower than the month before?), enterprise sales cycle length (is it stable, lengthening, or shortening?), and the percentage of enterprise deals that include a mandatory reference call. If churn velocity has not decreased by 15% by day 30, schedule a mid-engagement review to assess whether the fractional CRO's approach is working or if you need to pivot to a full-time hire.

Sources